Home Categories Pharmaceutical intermediates Ivacaftor (VX-770)
A8362312

Ivacaftor (VX-770) , ≥98% , 873054-44-5

Synonym(s):
CFTR Potentiator, VX-770 - CAS 873054-44-5 - Calbiochem;N-(5-Hydroxy-2,4- bis(2-methyl-2-propanyl)phenyl]-4-oxo-1,4-dihydro-3-quinolinecarboxamide, Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, VX 770, Ivacaftor, Kalydeco;N-(5-Hydroxy-2,4-bis(2-methyl-2-propanyl)phenyl]-4-oxo-1,4-dihydro-3-quinolinecarboxamide, Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, VX 770, Ivacaftor, Kalydeco

CAS NO.:873054-44-5

Empirical Formula: C24H28N2O3

Molecular Weight: 392.49

MDL number: MFCD17171361

Pack Size Price Stock Quantity
5MG RMB143.20 In Stock
10MG RMB181.60 In Stock
50MG RMB539.20 In Stock
100mg RMB799.20 In Stock
250mg RMB1850.40 In Stock
500mg RMB2559.20 In Stock
1g RMB4759.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 212-215°C
Boiling point: 550.4±50.0 °C(Predicted)
Density  1.187
storage temp.  Refrigerator
solubility  DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
pka 11.08±0.23(Predicted)
form  Solid
color  White to Light Brown
InChI InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)
InChIKey PURKAOJPTOLRMP-UHFFFAOYSA-N
SMILES N1C2=C(C=CC=C2)C(=O)C(C(NC2=CC(O)=C(C(C)(C)C)C=C2C(C)(C)C)=O)=C1

Description and Uses

In January 2012, the US FDA approved ivacaftor for the treatment of cystic fibrosis (CF) in patients who have the G551D mutation of the CF transmembrane regulator (CFTR) and are at least 6 years old. Ivacaftor (also known as VX-770) is a CFTR potentiator that increases the open probability of CFTR, thus increasing chloride secretion particularly in the 5% of CF patients with the G551D/F508 gating/ processing mutation. Ivacaftor was discovered by medicinal chemistry optimization of a lead scaffold identified through high-throughput screening of a 228,000 compound collection. In cultured bronchial epithelial cells from a CF patient with F508del, ivacaftor increased chloride secretion (EC50=81 nM). Preparation of ivacaftor is accomplished via a multistep synthesis oftwointermediates, 4-oxo-1,4-dihydroquinoline-3-carboxylic acid and 5-amino-di-tert-butylphenyl methyl carbonate, which are coupled using propane phosphonic acid anhydride (T3P) to afford the amide; deprotection of the phenol then provides ivacaftor.

Ivacaftor (VX-770, Kalydeco) is a potentiator of CFTR targeting G551D-CFTR and F508del-CFTR with EC50 of 100 nM and 25 nM, respectively

Safety

Symbol(GHS) 
GHS08,GHS07
Signal word  Warning
Hazard statements  H361-H319-H315-H335
Precautionary statements  P264-P280-P302+P352-P321-P332+P313-P362-P201-P202-P281-P308+P313-P405-P501-P264-P280-P305+P351+P338-P337+P313P
HS Code  29333990

RELATED PRODUCTS